Princeton-based drug researcher opens Tokyo office

Vince Calio//May 22, 2018//

Listen to this article

WIRB-Copernicus Group, a Princeton-based medical research group, has opened a Tokyo office to expand its capabilities in conducting global clinical trials.WIRB-Copernicus Group, a Princeton-based medical research group, has opened a Tokyo office to expand its capabilities in conducting global clinical trials.

The company’s Tokyo office will have a particular focus conducting trials for drug and diagnostic development for oncology and central nervous system diseases. WCG said the opening of the office helps alleviate some of the difficulties in rounding up appropriate sub populations for clinical trials.

In the past decade, Asia has become an increasingly attractive destination for clinical research, with a clinical trials infrastructure designed to foster speed, cost effectiveness and quality.